Chemicals

Amyris to acquire Oobli, adding fermentation-derived sweet proteins

The deal combines Amyris’s strain engineering and manufacturing scale with Oobli’s sweet protein portfolio and fermentation expertise.

Erik LindqvistNovember 16, 20265 min read4 views
Fermentation vessels and laboratory glassware surround a conceptual still life of protein powder and fruit-derived ingredient forms.

Amyris, Inc., an Emeryville, California-based biomanufacturing company, will acquire Oobli Inc., a Davis, California-based developer of fermentation-derived sweet proteins. The companies said the transaction is expected to close in the coming weeks.

Amyris said the deal would combine its strain engineering, manufacturing depth and commercial capabilities with Oobli’s protein fermentation expertise. It follows Amyris’s expansion earlier this year of manufacturing capacity at its advanced fermentation facility in Barra Bonita, Brazil. Amyris described the acquisition as a commercial and technology expansion intended to accelerate its work in protein- and peptide-based solutions across end markets.

Amyris said Oobli’s commercial portfolio of sweet proteins would be the first to benefit from the combined platform.

Sweet protein portfolio

Oobli has spent the past decade refining a fermentation process for producing sweet proteins that occur naturally in rare fruits and berries near the equator. Oobli describes its sweet proteins as the first of their kind in the sugar-reduction category. According to Oobli, these proteins are hundreds to thousands of times sweeter than sugar, bind directly to sweet taste receptors and are metabolized by the body as protein. The company says they deliver sweetness without gut disruption or blood sugar spikes.

Oobli’s portfolio includes three sweet proteins:

  • Oubli Fruit Sweet Protein, scientifically known as brazzein
  • Serendipity Berry Sweet Protein, known as monellin
  • Katemfe Fruit Sweet Protein, known as thaumatin

Oobli says the ingredients have FDA GRAS status for use as an ingredient and are FEMA GRAS-affirmed for use as a natural flavor. Oobli says growing consumer awareness of metabolic health and sugar reduction is creating demand for tools that brands can use across sports and nutrition, dairy, beverages, chocolate, bakery and confectionery.

Executive views

Amyris CEO Kathy Fortmann said Oobli’s commercial and technology platform complements Amyris’s own. She said combining Oobli’s protein expertise with Amyris’s strain engineering, manufacturing scale and commercial reach could broaden capabilities in food and beverage, personal care, flavor and fragrance, agriculture and other markets.

Oobli CEO Ali Wing said the company had long sought a way to deliver the sweet taste consumers want without trade-offs to health and the environment. She said joining Amyris would give Oobli the scale and resources to pursue its ambition of making sweet proteins a global standard for sweetness solutions.

Fortmann said Amyris has seen biomanufactured solutions succeed when they align with consumer demand and market needs. She said Oobli’s platform offers brands a way to address sweet taste, sugar reduction and clean-label goals at the same time.

Amyris said Oobli’s existing customer commitments and brand partnerships will continue without interruption as the portfolio expands within Amyris.